Big Science may be making headway according to scientists, but an article in US News and World Report disparages the whoppingly expensive Cancer Genome Project as only being a pilot that hasn't quite gotten off the ground due to flat funding and "cultural resistance to strategically directed big science." With a budget of $100 million, TCGA is "a costly effort even by genomics standards," writes Daniel MacArthur at Genetic Future.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.